Pentoxifylline attenuates the development of hepatic fibrosis by inhibiting TNF-α, which reduces mortality in AH and may decrease the incidence of hepatorenal syndrome (Tyagi et al., 2011). The gene discussed is TNF; the disease is hepatorenal syndrome.